Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice
- 31 July 2000
- journal article
- Published by Wiley in FEBS Letters
- Vol. 478 (3) , 205-208
- https://doi.org/10.1016/s0014-5793(00)01852-4
Abstract
X‐linked adrenoleukodystrophy (ALD) is a genetic demyelinating disorder characterized by accumulation of very long chain fatty acid (VLCFA) in tissues. Lovastatin, an inhibitor of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase, normalizes VLCFA in fibroblasts and plasma from ALD patients. We dietary treated ALD mice with simvastatin, an analog of lovastatin with similar pharmacokinetics and effects on plasma VLCFA in ALD patients at 20 or 60 mg/kg/day for 6–12 weeks. No decrease of VLCFA content was observed in mouse tissues, including the brain. A significant increase of VLCFA was rather observed in the brain of ALD mice at 60 mg/kg/day.Keywords
This publication has 31 references indexed in Scilit:
- Efficacy and safety of Simvastatin 80 mg/day in hypercholesterolemic patientsThe American Journal of Cardiology, 1998
- Retroviral Transfer and Long-Term Expression of the Adrenoleukodystrophy Gene in Human CD34+CellsHuman Gene Therapy, 1998
- Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison studyDiabetes Care, 1998
- cDNA Cloning and mRNA Expression of the Human Adrenoleukodystrophy Related Protein (ALDRP), a Peroxisomal ABC TransporterBiochemical and Biophysical Research Communications, 1997
- Primary Structure of Human PMP69, a Putative Peroxisomal ABC-TransporterBiochemical and Biophysical Research Communications, 1997
- Adrenoleukodystrophy Protein-Deficient Mice Represent Abnormality of Very Long Chain Fatty Acid MetabolismBiochemical and Biophysical Research Communications, 1997
- Clinical Pharmacokinetics of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase InhibitorsClinical Pharmacokinetics, 1996
- Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductaseThe American Journal of Cardiology, 1994
- Tissue selectivity of hydroxymethylglutaryl coenzyme a (HMG CoA) reductase inhibitorsPharmacology & Therapeutics, 1993
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976